The Equity Club

The Equity Club is an Italian private investment firm structured as a club-deal vehicle rather than a biotechnology, pharmaceutical, or healthcare operating company. It was promoted by its management team and Mediobanca to support mid-cap companies with solid fundamentals and ambitious growth plans. The firm invests across multiple sectors, including technology, hospitality, manufacturing, cosmetics, and selectively biopharmaceuticals through portfolio investments such as Philogen. The Equity Club does not appear to develop its own therapeutic products, drug pipeline, or healthcare technologies. Instead, it provides capital, strategic support, and governance involvement to portfolio companies.